s u m m a r y Background: Incidence of actinic keratosis (AKs) and nonmelanoma skin cancer appears to be increasing worldwide due to increasing levels of ultraviolet radiation, lifestyle changes, and an aging population. However, there is no population-based study focusing on AKs among Asian population. We aimed to investigate the incidence, the treatment pattern, the medical utilization and the risk of malignant neoplasm of the AKs patients in Taiwan.
Introduction
Actinic keratosis (AKs) or solar keratosis is a cutaneous lesion that results from the proliferation of atypical epidermal keratinocytes and also represents a step in the development of squamous cell carcinoma (SCC) 1, 2 . The diagnosis of AKs is more important for the geriatric population than young individuals because not only does the incidence of malignant skin lesions increase with age but diagnosis of AKs also places the patients in a high-risk group for a subsequent development of skin cancer 3 .
Several reports provide estimates on the growing numbers of affected people and the economic burden of treatment 4 . In US, one study based on data from the National Ambulatory Medical Care Survey indicated that 5.2 million visits occurred annually for AK during the periods of 2000 through 2003 5 . A study in 2005 estimated that AK affects more than 58 million people 6 . In northern hemisphere populations, 11%e25% of adults have at least one AK, compared with 40%e60% of adult Australians 7, 8 . The prevalence rate reported in England in 2000 was 15.4% in men and 5.9% in women older than 40 years 9 . These rates increased to 34.1% and 18.2%, respectively, at 70 years of age, when prevalence was most strongly related to 2 objective signs of sun exposure: solar elastosis and lentigines 9 . Although these studies clearly demonstrate the high prevalence of AK, there are no information focusing on the epidemiology of actinic keratosis regarding among Asian population. Updated investigation might be informative by providing a more contemporary prevalence estimate.
Moreover, prior studies had suggested the worldwide incidence of nonmelanoma skin cancer (basal cell carcinoma, and SCC) has increased by 4%e8% per year since 1960 10 . Meanwhile, a recent South Korean research also pointed to a 2.14 fold increase in the incidence of AKs in relation to the last decade of the last century 11 . The AKs resulted in the growing numbers of affected people and economic burden of treatment 1 . Early detection of skin cancer in the pre-SCC stage with proper management may suppress the rise in the incidence of SCC. In light of the above, AKs has become an important public health problem. However, much of the data on the epidemiology for AKs are derived from studies in light-skinned Caucasians, and there is no national population-based study focusing on AKs among a Chinese population.
We conducted a nationwide retrospective cohort study to investigate the frequency of AKs diagnosis, the type of AKs treatment, and the medical utilization of AKs patients in Taiwan. The risk of malignant neoplasm in AKs patients was also evaluated. Updated investigation in this study will be informative by providing a more contemporary incidence estimate.
Materials and methods

Data source
We used the National Health Insurance Research Database (NHIRD), which covered 99% of nearly 23 million people in Taiwan, to conduct a retrospective cohort study during 2003e2011. The NHIRD contained all the original claim data registration files and original claims data for reimbursement.
Study population and cohort entry/exit date
To conduct a retrospective cohort study with a 9-year observation period (2003e2011). The inclusion criteria was patients who had at least two outpatient visits or one hospital admission of AK International Classification of Disease-Clinical (ICD-9-CM) code (702.0) identified by dermatologist. We defined an individual's entry date as the date of first diagnosis of AK from 1 January 2004 to 31 December 2011. We excluded patients who developed skin malignant neoplasm (ICD-9 code: 173) before the entry date. An individual's cohort exit date would be the earlier of the first diagnosis of skin malignant neoplasm (ICD-9 code: 173), or end of the study period. A total of 35,933 patients with AKs were included in this analysis.
Actinic keratosis treatment and study outcomes
For all study patients, procedural treatment and medical treatment of AK during the whole period of follow-up after the entry date were used, including cryotherapy, electro cauterization, excision of skin (facial skin, skin), and 5-fluorouracil. All information on procedural and medical treatment used by individual patients was obtained from the NHIRD. The frequency of procedural treatment use was defined as number of outpatient visits within the whole follow-up years. The outcome of interest is skin malignant neoplasm (ICD-9 code: 173).
Statistical analysis
All statistical tests were two sided, with an alpha level of 0.05, and the confidence intervals (CIs) were 95%. Cox proportional hazards model was used to evaluate whether AK is an important risk factor for skin malignant neoplasm. We also adjusted for potential confounders in the multivariable Cox models, including patient demographics (age and gender), prior history of immunosuppressive drugs use, procedural and medical treatments during the follow-up period. Data management and statistical analyses were performed using SAS version 9.2 (SAS Institution Inc, Cary, North Carolina) and Microsoft Excel 2013 software.
Ethical approval
This study protocol was approved by Joint Institutional Review Board established by Medical Research Ethics Foundation.
Results
There were 36,858 patients who were admitted for the first time with a primary diagnosis of AKs between 2004 and 2010. After excluding 925 patients who had skin malignant neoplasm before entry date, a total of 35,933 patients were included in the analysis of procedural treatment of AKs and skin malignant neoplasm. The overall incidence rate for AKs from 2004 to 2011 ranged from 1.66 to 2.18 per ten thousand people. We found the incidence rate for AKs among elderly patients (range from 7.22 to 10.59) was higher than non-elderly (range from 0.87 to 1.13) ( Figure 1 ). The trend of decreasing incidence of actinic keratosis in elderly patients was also found.
Of the 35,933 patients with AKs, 17,004 (47.3%) were elderly patients, and 18,929 were non-elderly patients. At the baseline, we found elderly patients had a higher proportion of male, lived in southern Taiwan and others area, diagnosed in medical center or regional or district hospital, used immunosuppressive drugs prior to entry date, underwent cryotherapy, excision of facial skin, and excision of skin (except face) surgery than non-elderly patients ( Table 1) .
Nine hundred and twenty-three patients were identified with skin malignant neoplasm after diagnosis of AKs, the overall incidence rate of skin malignant neoplasm was 67.07 per 10,000 patient-year (95%CI, 62.88e71.53). Ninety-seven of the 18,929 nonelderly patients and 826 of the 17,004 elderly patients were identified with skin malignant neoplasm after diagnosis of AKs (incidence rates: 13.80 [95%CI, 11.31e16.84], and 122.66 [95%CI, 114.58e131.32] per 10,000 patient-year, respectively) ( Table 2 ).
In the multivariable-adjusted Cox proportional hazards model, we found the elderly (HR ¼ 8.85, 95%CI ¼ 7.06e11.08), female (HR ¼ 1.26, 95%CI ¼ 1.11e1.44), residence in central area (HR ¼ 1.33, 95%CI ¼ 1.08e1.64) or southern and others area (HR ¼ 1.51, 95% CI ¼ 1.29e1.78) were significant risk factors for skin malignant neoplasm. Patients receiving treatments of cryotherapy (HR ¼ 0.82, 95%CI ¼ 0.69e0.97) and electro cauterization (HR ¼ 0.56, 95% CI ¼ 0.39e0.78) for AKs was associated with decreased risk of skin malignant neoplasm (Table 3) .
Discussion
The population-based estimates of the incidence of AKs are scanty, even for Caucasians. In 1986, Marks evaluated the incidence of AKs in 1040 Australian people aged more than 40 years and found 60% of patients with AKs at baseline developed new lesions during 12 months of follow-up, compared with only 19% of those who were lesion-free on the first examination 12 . Another study by Nestor et al. reported the incidence of treated AKs was 446~11,045 per 10,000 people per year in two health maintenance organization populations in South Florida, which many be the highest recorded incidences in the world 13 . However, growing evidence had showed precancerous and malignant skin alterations were relatively infrequent in Asians than Caucasians. A recent study of Japanese residents of Kauai, Hawaii, suggested that the average annual incidence of SCC among Caucasians was five times higher and that of BCC was 14 times higher than Japanese 14 . Suzuki et al. conducted a recent study evaluating 4867 Japanese residents of Hyogo and showed that the incidence of AKs was approximately 20 per 10,000 people per year. Compared with this study, the incidence of AKs in our study is even much lower (2.27~3.75 vs. 8.6~29.1 per 10,000 people per year) 14 . Although the direct comparison of these values 1 . Actinic keratosis. The incidence rate with stratification by age. were not standardized for age sex or calculating methods possibly resulting in inaccuracy, the ethnic differences in the incidence of AKs remained noteworthy, probably suggesting an effect of skin color.
Most of the previous research, mainly focusing on the prevalence, also showed the prevalence of AKs varied according to various UV radiation levels in different geographic areas (Australia > United States of America > Europe) and the studied populations. Accumulating studies had shown that in northern hemisphere populations, 11%e25% of adults have at least one AKs, compared with 40%e60% of adult Australians, who live closer to the equator and were thought to have the highest known rate of AKs in the world 9,15e18 . In the USA, the prevalence is reported to be 11%e 25% 7, 18, 19 . With a prevalence of 40%e60%, the incidence is highest in people living closest to the equator 7, 19 . In UK, the prevalence rate reported in England in 2000 was 15.4% in men and 5.9% in women older than 40 years 9 . The South Wales Skin Cancer Study reported an AKs prevalence of 23% in South Wales 12 .
Consistent with previous researches 7, 16, 20 , our study showed that elderly patients have a higher risk of developing AKs compared with non-elderly. Green et al. had evaluated the prevalence of AKs in 2045 adults in Queensland and found that a higher rate of AKs presented in adults between the ages of 60 and 69 than those aged 20e29 years (68~79% vs. 5~10%) 16 . Another cohort study of 1040 people over the age of 40 in North Central Victoria also revealed that the mean age of individuals with AKs was significantly higher than in those without AKs (62 vs. 54 years) 12 .
Like other population-base study, our study also has several limitations. The NHIRD did not contain some behavioral risk factors and personal characteristics, such as ultraviolet index, occupational or recreational sun exposure, sunscreens use, history of sunburn episodes, place of birth, family history of skin malignancy. We therefore could not adjust for the effects of these factors in the development of AKs. Also, the treatments related with AKs might not be specific for the treatment of actinic keratosis for some were often applied for treatments of other common skin diseases which may co-existed with or occur subsequently after the diagnosis of actinic keratosis. However, we tried to include the treatment with the diagnosis of AKs only to obtain more precise information.
Using a nationwide population base data in Taiwan, this study demonstrates that the AKs incidence rate was low in the general population but particular high in the elderly population in Taiwan. The increasing trend was also found in the past decade. About 60% of patients received treatments and the cryotherapy was the major therapy. Our findings warrants further investigation into the relationship between actinic keratosis and the NMSC in Asians and may affect the approach toward primary prevention of NMSC in Asians with AKs.
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